According to Agenus 's latest financial reports the company's total liabilities are $0.46 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.46 B | -1.32% |
2022-12-31 | $0.46 B | 12.06% |
2021-12-31 | $0.41 B | -1.87% |
2020-12-31 | $0.42 B | 10.17% |
2019-12-31 | $0.38 B | 24.35% |
2018-12-31 | $0.31 B | 45.15% |
2017-12-31 | $0.21 B | 9.23% |
2016-12-31 | $0.19 B | 14.35% |
2015-12-31 | $0.17 B | 232.96% |
2014-12-31 | $51.5 M | 31.01% |
2013-12-31 | $39.31 M | -15.8% |
2012-12-31 | $46.69 M | 14.9% |
2011-12-31 | $40.63 M | -10.91% |
2010-12-31 | $45.61 M | -27.42% |
2009-12-31 | $62.84 M | -18.54% |
2008-12-31 | $77.15 M | -15.77% |
2007-12-31 | $91.59 M | 1.39% |
2006-12-31 | $90.34 M | 25.04% |
2005-12-31 | $72.25 M | 171.47% |
2004-12-31 | $26.61 M | -23.6% |
2003-12-31 | $34.83 M | 208.11% |
2002-12-31 | $11.3 M | -35.84% |
2001-12-31 | $17.62 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 21,268.17% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 14,834.19% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $65.67 B | 14,106.08% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | 12,624.62% | ๐ฌ๐ง UK |
Celldex Therapeutics CLDX | $36.45 M | -92.11% | ๐บ๐ธ USA |